Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Neuropharmacology|December 27, 2014
Allosteric activation of the 5-HT3AB receptor by mCPBGTimothy F Miles, Henry A Lester, Dennis A DoughertyBiophysical Journal|August 27, 2013
The 5-HT3AB receptor shows an A3B2 stoichiometry at the plasma membraneTimothy F Miles, Dennis A Dougherty, Henry A LesterACS Chemical Neuroscience|October 19, 2012
A coupled array of noncovalent interactions impacts the function of the 5-HT3A serotonin receptor in an agonist-specific wayTimothy F Miles, Kiowa S Bower, Henry A Lester, et al.Molecular Therapy. Methods & Clinical Development|August 29, 2022
Structural basis of receptor usage by the engineered capsid AAV-PHP.eBSeongmin Jang, Hao K Shen, Xiaozhe Ding, et al.Proteins|April 22, 2010
Polyglutamine fibrils are formed using a simple designed beta-hairpin modelMelanie H Smith, Timothy F Miles, Molly Sheehan, et al.Annual Review of Neuroscience|April 20, 2022
Adeno-Associated Virus Toolkit to Target Diverse Brain CellsRosemary C Challis, Sripriya Ravindra Kumar, Xinhong Chen, et al.Nature Methods|April 22, 2020
Multiplexed Cre-dependent selection yields systemic AAVs for targeting distinct brain cell typesSripriya Ravindra Kumar, Timothy F Miles, Xinhong Chen, et al.Elife|June 9, 2018
Viral GPCR US28 can signal in response to chemokine agonists of nearly unlimited structural degeneracyTimothy F Miles, Katja Spiess, Kevin M Jude, et al.Biomaterials|August 19, 2022
Multimodal imaging of capsid and cargo reveals differential brain targeting and liver detargeting of systemically-administered AAVsJai Woong Seo, Javier Ajenjo, Bo Wu, et al.Pageof 1